Oxford Nanopore Technologies
Oxford Nanopore Technologies is an innovative biotechnology company focused on enabling the analysis of any living thing, by any person, in any environment. Founded in 2005, the company produces a range of devices and reagents for direct nanopore-based analysis of nucleic acids and proteins, allowing for unprecedented insights into the living world.
Oxford Nanopore's products are used by scientists, clinicians, and researchers across a wide array of industries and applications, from disease diagnostics and environmental monitoring to industrial biotechnology, food safety, and more. The company's flagship product is the unique and highly versatile MinION nanopore sequencing device, enabling long-read sequencing without the need for traditional sequencing PCR or hybridization. Through its metrichor platform, Oxford Nanopore provides end-users with access to real-time data processing and analysis, enabling faster, deeper insights from a variety of samples.
Oxford Nanopore is unique in its ability to rapidly deliver results that would have previously taken days or weeks to achieve. The company's commitment to continuous improvement has driven many breakthroughs, such as the All Technology Solution (ATP), which promises to unlock the next level of insight from single-cell sequencing. Their efforts have been recognized in numerous awards, including a Frost & Sullivan 2016 Technology Innovation award.